Sab Biotherapeutics Inc. (SABS)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Davidson Kempner

Thomas Lenox Kempner

0 $0 -100% 0%
2.
Beryl Capital Management

David Alexander Witkin

0 $0 -100% 0%
3.
Saba Capital

Boaz Weinstein

0 $0 -100% 0%
4.
D E Shaw

D. E. Shaw

0 $0 -100% 0%
5. 0 $0 -100% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$0.88 1,740 5,232,304 2023-12-07 Filing
$0.90 5,000 5,000 2023-11-30 Filing
$0.89 11,000 219,001 2023-11-29 Filing
$0.73 10,000 Large Shareholder, Director 4,993,090 2022-09-13 Filing
$0.74 14,000 Large Shareholder, Officer, Director 5,230,564 2022-09-07 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$7.90 278 Officer 0 2021-10-26 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 0 $0 0%